Cargando…
The Association between Treatment with Bisphosphonates and the Risk of Atrial Fibrillation: A Meta-Analysis of Observational Studies
BACKGROUND: Osteoporosis is one of the most common diseases of the skeletal system, particularly occurring in older adults. Bisphosphonates are frequently used to treat osteoporosis and prevent bone fractures. Studies evaluating the association between treatment with bisphosphonate and the risk of a...
Autores principales: | Park, Ji-Hyun, Ko, Hae-Jin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Academy of Family Medicine
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8820972/ https://www.ncbi.nlm.nih.gov/pubmed/35130642 http://dx.doi.org/10.4082/kjfm.21.0110 |
Ejemplares similares
-
Bisphosphonates and risk of atrial fibrillation: a meta-analysis
por: Kim, Seo Young, et al.
Publicado: (2010) -
Bisphosphonates and atrial fibrillation: Bayesian meta-analyses of randomized controlled trials and observational studies
por: Mak, Anselm, et al.
Publicado: (2009) -
Atrial fibrillation and the use of oral bisphosphonates
por: Pazianas, Michael, et al.
Publicado: (2011) -
Risk of atrial fibrillation among bisphosphonate users: a multicenter, population-based, Italian study
por: Herrera, L., et al.
Publicado: (2015) -
Vitamin D and bisphosphonates therapies for osteoporosis are associated with different risks of atrial fibrillation in women: A nationwide population-based analysis
por: Yang, Hung-Yu, et al.
Publicado: (2018)